Where does Palliare Limited rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Palliare Limited ranks #49,466 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Palliare Limited hold?

Palliare Limited holds 5 US utility patents granted between 2021 and 2025, spanning 3 technology areas.

What is Palliare Limited's Innovation Score?

Palliare Limited has an Innovation Score of 39.6 out of 100 (top 38% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Palliare Limited focus on?

Palliare Limited's top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 2 patents. Grants appear in 3 CPC subclasses total.

Is Palliare Limited's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Palliare Limited.

What does claim depth mean for Palliare Limited's patents?

Palliare Limited's patents average 12.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Palliare Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Palliare Limited

USPTO PatentsView assignee record - 5 granted patents across 3 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Palliare ranks #49,466 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 3 technology areas.

#49,466
of 49,997 US assignees by volume: Top 38%
by Innovation Score (39.6/100): 12.2
avg claims per patent

USPTO PatentsView assignee plate

Corpus R49466 · Foreign Corporation #49,466 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 5 grants
BOTTOM-DECILE #49,466/49,997
PHOTO-FINISH Paladin Labs
CPC-NARROW A61B · 3 areas
INNOV-THIN 39.6/100
CLAIMS-RICH 12.2 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2021–2025 · 5y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Paladin Labs Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Natus Medical… · near

40
Palliare · this assignee

40
PointSource · near

40
Taiwan FU Hsing… · near

40
Vaccinex · near

40
3D Lighting… · lowest

7

What this shows Palliare's Innovation Score is 39.6/100 (top 38% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Palliare's grants concentrate

Palliare Limited is a focused PatentsView assignee: 3 CPC subclasses with 40% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2022 (2 grants) versus a trough of 1 in 2021. By volume, Palliare sits between Paladin Labs Inc. and PanaceaNano, Inc..

Palliare's three-year grant acceleration

Palliare Limited shows 3 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Paladin Labs

5
Palatiumcare

5
Palatov Group

5
Palitronica

5
Palm Silage

5
Panoptica

5
Panacea Biomatx

5
Panaceanano

5
Palliare ◀

5

What this shows Palliare holds 5 patents at rank #49,655, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Palliare

By rank, the assignees closest to #49,655 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Palliare's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Palliare, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (40 here).

PointSource Technologies, LLC 40 Natus Medical Incorporated 40 Vaccinex, Inc. 40 Taiwan FU Hsing Industrial Co., Ltd. 40

Palliare's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

40 Top 38% higher than 62% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2021–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table

Palliare Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2021	1	20.0%
2022	2	40.0%
2023	1	20.0%
2025partial year	1	20.0%

Which technologies does Palliare Limited patent most?

A61B - DIAGNOSIS; SURGERY; Identification 2

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 2

A61D - Veterinary Instruments, Implements, Tools, OR Methods 1

Top 3 of 3 technology areas

Where it ranks

Overall rank by patents

#49,466

of 49,997 tracked assignees

Innovation Score

39.6 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Palliare Limited's patent record in context - here's where to go next.

Palliare Limited's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 40% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #49,466 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Palliare Limited against Paladin Labs Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 39.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.